Valneva Commences Manufacturing of its Inactivated, Adjuvanted COVID-19 Vaccine, Completes Phase 1/2 Study Recruitment

    NEXT STORY
    Global Antigen Rapid Test Kit Market, Forecast & Opportunities, 2026 – Over-the-counter (OTC) Rapid Test Kit v/s Professional Rapid Test Kit
    PREV STORY
    Pandemics and infectious diseases top survey of current risks
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ziopharm Oncology Provides Controlled IL-12 Update with Positive Data from Phase 1 Trial Presented at Annual Meeting of the Society for Neuro-Oncology

    Ad-RTS-hIL-12 plus 20mg veledimex (Controlled IL-12) determined to be preferred dosing with low-dose steroids ...

    author_avatar
    NASDAQ Market News

    Correction new weekday: Oncology Venture: Kallelse till extra bolagsstämma

    INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLINGNOTICE TO CONVENE EXTRAORDINARY GENERAL MEETINGKALLELSE TILL EXTRA BOLAGSSTÄMMA Der indkaldes ...

    author_avatar
    NASDAQ Market News

    Bone Therapeutics SA : completes patient recruitment for pivotal interim analysis of Phase III Osteonecrosis trial with PREOB®

    Regulated information Bone Therapeutics completes patient recruitment for pivotal interim analysis of Phase III ...

    author_avatar
    NASDAQ Market News